Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Solve your real-world data problems with support from this valuable network of global institutions.
Work with like-minded groups committed to better data use in areas like rare disease, cancer, and infectious disease.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
13 Jan 2020
Edward Dove (University of Edinburgh), Yann Joly (McGill University), and Jaime Guidry Auvil (National Institutes of Health) have been named new GA4GH Work Stream Leads and members of the GA4GH Steering Committee.
The Global Alliance for Genomics and Health (GA4GH) welcomes three new members to its Steering Committee, naming Edward Dove of University of Edinburgh and Yann Joly of McGill University as co-leads of the Regulatory & Ethics Work Stream (REWS) and adding Jaime Guidry Auvil of the US National Institutes of Health (NIH) as co-lead of the Data Use & Researcher Identities (DURI) Work Stream to serve alongside Tomi Nyrönen, of ELIXIR Finland.
Dove and Joly replace Bartha Knoppers of McGill University and Madeleine Murtagh of Newcastle University. Knoppers served as founding chair of the REWS since GA4GH was launched in 2013 while Murtagh served since the launch of GA4GH Connect in 2016.
Dove is a Lecturer in Health Law and Regulation at the Law School, University of Edinburgh. He holds a Bachelor of Arts degree (BA) in Political Science and Civil Law and Common Law degrees (BCL, LLB) from McGill University, a Master of Laws degree (LLM) from Columbia University, and a PhD in Law from the University of Edinburgh. His primary research interests are in the areas of regulation of biomedical research, research ethics oversight, data protection law issues in health research, and governance of international research collaboration. His current research focus lies in assessing how EU and UK data protection law impacts health research and in conducting empirical studies of NHS research ethics committees and other regulatory actors in health research. Dove is an Editorial Board member of Asian Bioethics Review. He served as founding Chair of the GA4GH General Data Protection Regulation (GDPR) and International Health Data Sharing Forum as well as the REWS coordinator from 2013 to 2014.
Joly is the Research Director of the Centre of Genomics and Policy (CGP) and an Associate Professor at the Department of Human Genetics at McGill University. He was named advocatus emeritus by the Quebec Bar in 2012 and Fellow of the Canadian Academy of Health Sciences in 2017. Joly is a member of the Canadian Commission for UNESCO (CCU); chair of the Bioethics Workgroup of the International Human Epigenome Consortium (IHEC); former Chair of the Ethics and Governance Committee of the International Cancer Genome Consortium (ICGC); and a member of the Human Genome Organization (HUGO) Committee on Ethics, Law and Society (CELS). Joly’s research interests lie at the interface of the fields of scientific knowledge, health law (biotechnology and other emerging health technologies) and bioethics. He created the first international genetic discrimination observatory (GDO) in 2018. Joly, who was already involved in two GA4GH driver projects (EpiShare and CanDIG) says he is ‘‘enthusiastic about the opportunity to expand his contribution to play a more prominent role in the organisation policymaking front as REWS co-lead’’.
Guidry Auvil is the director of the Office of Data Sharing at the National Cancer Institute (NCI) within the NIH. Since joining NCI in 2010, Guidry Auvil has coordinated programmatic and data sharing activities within NCI’s Center for Cancer Genomics, most extensively for the pediatric cancer genomics Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative. She additionally serves as an NCI representative on leadership and working group teams to provide guidance for the Gabriella Miller Kids First Pediatric Research Program through the NIH Office of the Director. Prior to her time at NCI, Guidry Auvil led clinical and biomedical translational research studies within academia (Veteran Affairs Hospital of Baltimore and the University of Maryland Medical School) and the biotechnology industry (BBI Biotech, Inc.). Guidry Auvil received her doctorate in tumor biology from Georgetown University Medical School, where her research on adhesion molecule, cadherin-11, in metastatic cancers led to the development of a patented small molecule inhibitor intended for the treatment of both bone metastatic cancers and rheumatoid arthritis.
GA4GH is pleased to announce these leadership transitions and looks forward to a fruitful year for all of the eight Work Streams. In particular, the group plans to roll out a new strategic Roadmap in October at its 8th annual Plenary Meeting, to be held this year in Melbourne, Australia from 30 September to 2 October.